Advertisement

Short term colectomy rate and mortality for severe ulcerative colitis in the last 40 years. Has something changed?

Published:February 04, 2016DOI:https://doi.org/10.1016/j.dld.2015.12.014

      Abstract

      Background

      About 20% of ulcerative colitis patients will experience a severe attack during the course of the disease. Intensive treatment, early surgery and, more recently, “rescue therapies” improved prognosis.

      Aims

      To evaluate in-hospital colectomy and mortality rates for severe ulcerative colitis over 40 years in two referral centres.

      Methods

      All in-patients with severe ulcerative colitis from 1976 to 2010 were considered. 159 patients were assigned to 4 cohorts: cohort 1 n = 34 (1976–1980); cohort 2 n = 29 (1986–1990); cohort 3 n = 45 (1996–2000); cohort 4 n = 51 (2006–2010).

      Results

      The colectomy rate was 64.7%, 62.0%, 44.4% and 9.8%, respectively, in the four cohorts (p < 0.0001). The mortality rate decreased from 8.8% in cohort 1, to 0 in cohort 4 (p = 0.04). Infliximab was used only in cohort 4 (17 patients).

      Conclusions

      A significant reduction of colectomy and mortality rates in severe ulcerative colitis was observed in the last 40 years. Better management of patients, reduced attitude to operate severe ulcerative colitis, as well as the use of Infliximab in the last cohort, all could have contributed to the improved outcome.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Edwards F.C.
        • Truelove S.C.
        The course and prognosis of ulcerative colitis.
        Gut. 1963; 4: 299-315
        • Hyde G.M.
        • Jewell D.P.
        Review article: the management of severe ulcerative colitis.
        Alimentary Pharmacology and Therapeutics. 1997; 11: 419-424
        • Rice-Oxley J.M.
        • Truelove S.C.
        Ulcerative colitis: course and prognosis.
        Lancet. 1950; i: 663-666
        • Truelove S.C.
        • Witts L.J.
        Cortisone in ulcerative colitis: final report on a therapeutic trial.
        British Medical Journal. 1955; 2: 1041-1048
        • Truelove S.C.
        • Jewell D.P.
        Intensive intravenous regimen for severe attacks of ulcerative colitis.
        Lancet. 1974; i: 1067-1070
        • Gallagher N.D.
        • Goulston S.S.M.
        • Wyndham N.
        • et al.
        The management of fulminant ulcerative colitis.
        Gut. 1962; 3: 306-311
        • Edward F.C.
        • Truelove S.C.
        The course and prognosis of ulcerative colitis.
        Gut. 1963; 4: 299-315
        • Goligher J.C.
        • Hoffman D.C.
        • deDombal F.T.
        Surgical treatment of severe attacks of ulcerative colitis with special reference to the advantages of early operation.
        British Medical Journal. 1970; 4: 703-706
        • Flatmark A.
        • Fretheim B.
        • Gjone E.
        Early colectomy in severe ulcerative colitis.
        Scandinavian Journal of Gastroenterology. 1975; 10: 427-431
        • Truelove S.C.
        • Lee E.G.
        • Willoughby C.P.
        • et al.
        Further experience in the treatment of severe attacks of ulcerative colitis.
        Lancet. 1978; ii: 1086-1088
        • Jarnerot G.
        • Rolny P.
        • Sandberg-Gertzen H.
        Intensive intravenous treatment of ulcerative colitis.
        Gastroenterology. 1985; 89: 1005-1013
        • Caprilli R.
        • Vernia P.
        • Latella G.
        • et al.
        Early recognition of toxic megacolon.
        Journal of Clinical Gastroenterology. 1987; 9: 160-164
        • Selinger C.P.
        • Leong R.W.
        Mortality from inflammatory bowel diseases.
        Inflammatory Bowel Diseases. 2012; 18: 1566-1572
        • Nicholls R.J.
        • Clark D.N.
        • Kelso L.
        • et al.
        Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis.
        Alimentary Pharmacology and Therapeutics. 2010; 31: 1310-1321
        • Tøttrup A.
        • Erichsen R.
        • Sværke C.
        • et al.
        Thirty-day mortality after elective and emergency total colectomy in Danish patients with inflammatory bowel disease: a population-based nationwide cohort study.
        BMJ Open. 2012; 2: e000823https://doi.org/10.1136/bmjopen-2012-000823
        • Kaplan G.
        • McCarthy E.P.
        • Ayanian J.Z.
        • et al.
        Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis.
        Gastroenterology. 2008; 134: 680-687
        • Turner D.
        • Walsh C.M.
        • Steinhart H.
        • et al.
        Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and meta-regression.
        Clinical Gastroenterology and Hepatology. 2007; 5: 103-110
        • Gustavsson A.
        • Halfvarson J.
        • Magnuson A.
        • et al.
        Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era.
        American Journal of Gastroenterology. 2007; 102: 2513-2519
        • Cohen R.D.
        • Brodsky A.L.
        • Hanauer S.B.
        A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporine.
        Inflammatory Bowel Diseases. 1999; 5: 1-10
        • Lichtiger S.
        • Present D.H.
        • Kornbluth A.
        • et al.
        Cyclosporine in severe ulcerative colitis refractory to steroid therapy.
        New England Journal of Medicine. 1994; 330: 1841-1845
        • Moskovitz D.N.
        • Van Assche G.
        • Maenhout B.
        • et al.
        Incidence of colectomy during long-term follow-up after cyclosporine induced remission of severe ulcerative colitis.
        Clinical Gastroenterology and Hepatology. 2006; 4: 760-765
        • Gustavsson A.
        • Järnerot G.
        • Hertervig E.
        • et al.
        Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3-year follow-up of the Swedish-Danish controlled infliximab study.
        Alimentary Pharmacology & Therapeutics. 2010; 32: 984-989
        • Bressler B.
        • Law J.K.
        • Al Nahdi Sheraisher N.
        • et al.
        The use of infliximab for treatment of hospitalized patients with acute severe ulcerative colitis.
        Canadian Journal of Gastroenterology. 2008; 22: 937-940
        • Rigueiro M.
        • Curtis J.
        • Plevy S.
        Infliximab for hospitalized patients with severe ulcerative colitis.
        Journal of Clinical Gastroenterology. 2006; 40: 476-481
        • Jakobovits S.L.
        • Jewell D.P.
        • Travis S.P.
        Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
        Alimentary Pharmacology & Therapeutics. 2007; 25: 1055-1060
        • Lees C.W.
        • Heys D.
        • Ho G.T.
        • et al.
        Scottish Society of Gastroenterology Infliximab Group. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.
        Alimentary Pharmacology and Therapeutics. 2007; 26: 411-419
        • Aratari A.
        • Papi C.
        • Clemente V.
        • et al.
        Colectomy rate in acute severe ulcerative colitis in the infliximab era.
        Digestive and Liver Disease. 2008; 40: 821-826
        • Monterubbianesi R.
        • Aratari A.
        • Armuzzi A.
        • et al.
        Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy.
        Journal of Crohn's and Colitis. 2014; 8: 852-858
        • Lennard-Jones J.E.
        Classification of inflammatory bowel disease.
        Scandinavian Journal of Gastroenterology. 1989; 24: 2-6
        • Travis S.P.L.
        • Farrant J.M.
        • Ricketts C.
        • et al.
        Predicting outcome in severe ulcerative colitis.
        Gut. 1996; 38: 905-910
        • Jones J.H.
        • Chapman
        Definition of megacolon in colitis.
        Gut. 1969; 10: 562-564
        • Vernia P.
        • Colaneri O.
        • Tomei E.
        • et al.
        Intestinal gas in ulcerative colitis.
        Diseases of the Colon and Rectum. 1979; 22: 346-349
        • Meyers S.
        • Lerer P.K.
        • Feuer E.J.
        • et al.
        Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial.
        Journal of Clinical Gastroenterology. 1987; 9: 50-54
        • Meyers S.
        • Sachar D.B.
        • Goldberg J.D.
        • et al.
        Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trial.
        Gastroenterology. 1983; 85: 351
        • Molnár T.
        • Farkas K.
        • Nyári T.
        • et al.
        Response to first intravenous steroid therapy determines the subsequent risk of colectomy in ulcerative colitis patients.
        Journal of Gastrointestinal and Liver Diseases. 2011; 20: 359-363
        • Jarnerot G.
        • Hertervig E.
        • Friis-Liby I.
        • et al.
        Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.
        Gastroenterology. 2005; 128: 1805-1811
        • Costa J.
        • Magro F.
        • Caldeira D.
        • et al.
        Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease: a systematic review and meta-analysis.
        Inflammatory Bowel Diseases. 2013; 19: 2098-2110
        • Sjöberg M.
        • Magnuson A.
        • Björk J.
        • et al.
        Swedish Organization for the Study of Inflammatory Bowel Disease (SOIBD) Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients.
        Alimentary Pharmacology & Therapeutics. 2013; 38: 377-387
        • Kaplan G.G.
        • Seow C.H.
        • Ghosh S.
        • et al.
        Decreasing colectomy rates for ulcerative colitis: a population-based time trend study.
        American Journal of Gastroenterology. 2012; 107: 1879-1887
        • Frolkis A.D.
        • Dykeman J.
        • Negròn M.E.
        • et al.
        Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies.
        Gastroenterology. 2013; 145: 996-1006
        • Andersson P.
        • Söderholm J.D.
        Surgery in ulcerative colitis: indication and timing.
        Digestive Diseases. 2009; 27: 335-340
        • Latella G.
        • Vernia P.
        • Viscido A.
        • et al.
        GI distension in severe ulcerative colitis.
        American Journal of Gastroenterology. 2002; 97: 169-175
        • Alves A.
        • Panis Y.
        • Bouhnik Y.
        • et al.
        Subtotal colectomy for severe acute colitis: a 20-year experience of a tertiary care center with an aggressive and early surgical policy.
        Journal of the American College of Surgeons. 2003; 197: 379-385
        • Monstad I.
        • Hovde O.
        • Solberg I.C.
        • et al.
        Clinical course and prognosis in ulcerative colitis: results from population-based and observational studies.
        Annals of Gastroenterology. 2014; 27: 95-104
        • Roberts S.E.
        • Williams J.G.
        • Yeates D.
        • et al.
        Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies.
        BMJ. 2007; 335: 1033
        • Jess T.
        • Gamborg M.
        • Munkholm P.
        • et al.
        Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies.
        American Journal of Gastroenterology. 2007; 102: 609-617